Your SlideShare is downloading. ×
Bio marker strategies, llc   product pipeline analysis
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Bio marker strategies, llc product pipeline analysis

65
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
65
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. BioMarker Strategies, LLC - Product Pipeline AnalysisMarket Research Reports Distributor - Aarkstore.com have vast database on market research reports, companyfinancials, company profiles, SWOT analysis, company report, company statistics, strategy review, industryreport, industry research to provide excellent and innovative service to our report buyers.Aarkstore.com have very interactive search feature to browse across more than 2,50,000 business industryreports. We are built on the premise that reading is valuable, capable of stirring emotions and firing theimagination. Whether youre looking for new market research report product trends or competitive industryanalysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to makesure you get the right product every time.
  • 2. BioMarker Strategies, LLC - Product Pipeline AnalysisSummary BioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The companys product SnapPath, a novel automated tumor biopsy processing and testing system, is used to quickly test and analyze a patient’s live solid tumor sample at the point of biopsy. In addition to generating traditional DNA-based molecular profiles, it also generates phenotypic profiles of cancer patients. The company is headquartered at Baltimore in Maryland, the US. This report is a source for data, analysis and actionable intelligence on the BioMarker Strategies, LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
  • 3. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
  • 4. Reasons to Buy - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. - Design and develop your product development, marketing and sales strategies. - Exploit M&A opportunities by identifying market players with the most innovative pipeline. - Develop market-entry and market expansion strategies. - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high- value products that your competitor would add in its portfolio? – identify, understand and capitalize.
  • 5. List of Tables 3 List of Figures 4 Key Facts 5 BioMarker Strategies, LLC - Major Products and Services 6 BioMarker Strategies, LLC Pipeline Products by Equipment Type 7 BioMarker Strategies, LLC Pipeline Products by Development Stage 9 BioMarker Strategies, LLC Pipeline Products by Therapy Area 11 BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13 ABA-PROSTATE 14 ABA-PROSTATE Product Status 14 ABA-PROSTATE Product Description 14 Ex Vivo Biomarker Test - Breast Cancer 15 Ex Vivo Biomarker Test - Breast Cancer Product Status 15 Ex Vivo Biomarker Test - Breast Cancer Product Description 15 Ex Vivo Biomarker Test - Breast Cancer Product Patent Details 15 Ex Vivo Biomarker Test - Colon Cancer 19 Ex Vivo Biomarker Test - Colon Cancer Product Status 19 Ex Vivo Biomarker Test - Colon Cancer Product Description 19 Ex Vivo Biomarker Test - Lung Cancer 20 Ex Vivo Biomarker Test - Lung Cancer Product Status 20 Ex Vivo Biomarker Test - Lung Cancer Product Description 20 Ex Vivo Biomarker Test - Melanoma 21 Ex Vivo Biomarker Test - Melanoma Product Status 21 Ex Vivo Biomarker Test - Melanoma Product Description 21 Ex Vivo Biomarker Test - Pancreatic Cancer 22 Ex Vivo Biomarker Test - Pancreatic Cancer Product Status 22 Ex Vivo Biomarker Test - Pancreatic Cancer Product Description 22 Ex Vivo Biomarker Test - Solid Tumors 23 Ex Vivo Biomarker Test - Solid Tumors Product Status 23 Ex Vivo Biomarker Test - Solid Tumors Product Description 23 SnapPath Biomarker Testing System 24 SnapPath Biomarker Testing System Product Status 24 SnapPath Biomarker Testing System Product Description 24 SnapPath Biomarker Testing System Product Milestone 24 BioMarker Strategies, LLC - Key Competitors 26 BioMarker Strategies, LLC - Key Employees 27 BioMarker Strategies, LLC - Locations And Subsidiaries 28
  • 6. Head Office 28 Recent Developments 29 BioMarker Strategies, LLC, Recent Developments 29 Oct 03, 2012: BioMarker Strategies Appoints Jack Davis As Executive Chairman 29 May 27, 2011: BioMarker Strategies Appoints Glenn Miller To Board Of Directors As Chairman 29 Jan 03, 2011: BioMarker Strategies Appoints Three New Directors 29 Appendix 30 Methodology 30 About GlobalData 30 Contact Us 30 Disclaimer 30List of Figures BioMarker Strategies, LLC Key Pipeline Products by Equipment Type 1 BioMarker Strategies, LLC Pipeline Products by Equipment Type 7 BioMarker Strategies, LLC Pipeline Products by Development Stage 9 BioMarker Strategies, LLC Pipeline Products by Therapy Area 11 BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13
  • 7. List of TablesBioMarker Strategies, LLC, Key Facts 1BioMarker Strategies, LLC Key Pipeline Products by Equipment Type 1BioMarker Strategies, LLC Key Pipeline Products by Therapy Area 1BioMarker Strategies, LLC Key Pipeline Products by Development Stage 1BioMarker Strategies, LLC, Key Facts 5BioMarker Strategies, LLC, Major Products and Services 6BioMarker Strategies, LLC Number of Pipeline Products by Equipment Type 7BioMarker Strategies, LLC Pipeline Products by Equipment Type 8BioMarker Strategies, LLC Number of Pipeline Products by Development Stage 9BioMarker Strategies, LLC Pipeline Products by Development Stage 10BioMarker Strategies, LLC Number of Pipeline Products by Therapy Area 11BioMarker Strategies, LLC Pipeline Products by Therapy Area 12BioMarker Strategies, LLC Number of Pipeline Products By Milestone Summary 13BioMarker Strategies, LLC Pipeline Products by Milestone Summary 13ABA-PROSTATE - Product Status 14ABA-PROSTATE - Product Description 14Ex Vivo Biomarker Test - Breast Cancer - Product Status 15Ex Vivo Biomarker Test - Breast Cancer - Product Description 15Ex Vivo Biomarker Test - Breast Cancer - Patent Details1 15Ex Vivo Biomarker Test - Breast Cancer - Patent Details2 16Ex Vivo Biomarker Test - Breast Cancer - Patent Details3 16Ex Vivo Biomarker Test - Breast Cancer - Patent Details4 17Ex Vivo Biomarker Test - Breast Cancer - Patent Details5 17Ex Vivo Biomarker Test - Breast Cancer - Patent Details6 18Ex Vivo Biomarker Test - Colon Cancer - Product Status 19Ex Vivo Biomarker Test - Colon Cancer - Product Description 19Ex Vivo Biomarker Test - Lung Cancer - Product Status 20Ex Vivo Biomarker Test - Lung Cancer - Product Description 20Ex Vivo Biomarker Test - Melanoma - Product Status 21Ex Vivo Biomarker Test - Melanoma - Product Description 21Ex Vivo Biomarker Test - Pancreatic Cancer - Product Status 22Ex Vivo Biomarker Test - Pancreatic Cancer - Product Description 22Ex Vivo Biomarker Test - Solid Tumors - Product Status 23Ex Vivo Biomarker Test - Solid Tumors - Product Description 23SnapPath Biomarker Testing System - Product Status 24SnapPath Biomarker Testing System - Product Description 24SnapPath Biomarker Testing System - Product Milestone 24BioMarker Strategies, LLC, Key Employees 27
  • 8. Related ReportsFor more information, please visit:http://www.aarkstore.com/reports/BioMarker-Strategies-LLC-Product-Pipeline-Analysis-240207.htmlOr email us at contact@aarkstore.com or call +919272852585More Reportshttp://www.aarkstore.com/publishers/GlobalData-61.htmlRelated Reports• Competitive Intelligence: Leading Coagulation Market Players--Strategic Assessments of Major Suppliers and Emerging Mark• HeartSine Technologies, Inc. - Strategic SWOT Analysis Review• The Cooper Companies, Inc. (COO) - Financial and Strategic SWOT Analysis Review• Goold Health Systems, Inc. - Strategic SWOT Analysis Review• Atrium Medical Corporation - Strategic SWOT Analysis Review• iRhythm Technologies, Inc. - Strategic SWOT Analysis Review• Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review• Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review• Adpo Group NV - Strategic SWOT Analysis Review• Becton, Dickinson and Company (BDX) - Financial and Strategic SWOT Analysis Review
  • 9. Contact UsAarkstore E nterpriseT : +912227453309 elM obile No:+08149852585Email : contact@aarkstore.comW ebsite : http:/www.aarkstore.com /Blog: http:/www.emarketreports.com /http:/teju-aarkstoreenterprise.blogspot.in /Follow us on twitter: http:/twitter.com/ / aarkstoredotcomhttp:/in.linkedin.com/ aarkstore / in/http:/www.facebook.com/ / aarkstoreenterprise
  • 10. Contact UsAarkstore E nterpriseT : +912227453309 elM obile No:+08149852585Email : contact@aarkstore.comW ebsite : http:/www.aarkstore.com /Blog: http:/www.emarketreports.com /http:/teju-aarkstoreenterprise.blogspot.in /Follow us on twitter: http:/twitter.com/ / aarkstoredotcomhttp:/in.linkedin.com/ aarkstore / in/http:/www.facebook.com/ / aarkstoreenterprise